Wnt/β-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis

Main Article Content

Gayatri D Shirolkar
Sara Pasic
Jully Gogoi-Tiwari
Manoj K Bhat
John K Olynyk
Arun Dharmarajan
Janina EE Tirnitz-Parker


Chronic liver diseases (CLDs) are increasing in prevalence and their end-stage complications, namely, cirrhosis, liver failure and hepatocellular carcinoma represent major global challenges. The most common initiators of progressive CLD are viral hepatitis and long-term alcohol abuse as well as steatosis and steatohepatitis. Irrespective of the underlying aetiology, a common feature of CLD is the formation of hepatic ductular reactions, involving the proliferation of liver progenitor cells (LPCs) and their signalling to fibrosis-driving hepatic stellate cells. The Wnt/β-catenin pathway has been found to regulate development, stemness and differentiation, and alterations in its activity have been associated with tumour development. Recent data highlight the role of Wnt/β-catenin signalling in hepatic metabolism, steatosis and cancer, and suggest targeting of this pathway as a promising molecular strategy to potentially inhibit CLD progression and hepatocarcinogenesis.


Download data is not yet available.

Article Details

How to Cite
Shirolkar, G., Pasic, S., Gogoi-Tiwari, J., Bhat, M., Olynyk, J., Dharmarajan, A., & Tirnitz-Parker, J. (2018). Wnt/β-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis. Journal of Renal and Hepatic Disorders, 2(1), 1-9. https://doi.org/10.15586/jrenhep.2018.29
Review Hepatology